Keller H, Wimmenauer S, Rahner S, Reimer P, von Kleist S, Farthmann E H
Department of Surgery, University of Freiburg, Germany.
Eur Surg Res. 1995;27(4):258-68. doi: 10.1159/000129408.
Tumor-infiltrating lymphocytes (TILs) from colorectal cancers were separated from tumor cells by enzymatic and mechanical tissue disaggregation and discontinuous density gradients. Peripheral blood lymphocytes (PBLs) were isolated using the same procedure. The freshly separated TILs and PBLs were analyzed phenotypically by flow cytometry. The CD4+/CD8+ ratios of the freshly isolated TILs and PBLs were comparable (> 1 in both lymphocyte populations). CD25+, HLA-DR+ and CD56+ cells were significantly more frequent in the TIL than in the PBL population. However, the number of CD45RA+ cells was lower in the TILs as compared to PBLs, while CD29+ accumulated by about 90% in TILs. TILs and autologous PBLs were expanded in vitro with rIL-2. The mean rate of proliferation after 4 weeks was 642-fold in TIL cultures and 335-fold in PBLs. More than 90% of the rIL-2-expanded lymphocytes expressed CD2 and the great majority was CD29+. Stimulation with rIL-2 in vitro induced an outgrowth of CD56+ cells mainly in the TILs. Accordingly the expression of CD3+ and alpha/beta receptor in the TILs was low. Those cells which phenotypically represented lymphokine-activated killer cells displayed a lytic activity against the autologous tumor as well as against allogeneic K562 and Daudi targets. In accordance with the better proliferative response of TILs in long-term cultures with rIL-2, the lytic activity of TILs against autologous and allogeneic tumor targets was significantly higher as compared to PBLs.
通过酶解和机械组织解离以及不连续密度梯度从结直肠癌中分离肿瘤浸润淋巴细胞(TILs)与肿瘤细胞。采用相同程序分离外周血淋巴细胞(PBLs)。通过流式细胞术对新鲜分离的TILs和PBLs进行表型分析。新鲜分离的TILs和PBLs的CD4⁺/CD8⁺比值相当(两个淋巴细胞群体中该比值均>1)。CD25⁺、HLA-DR⁺和CD56⁺细胞在TIL中比在PBL群体中明显更常见。然而,与PBLs相比,TILs中CD45RA⁺细胞数量较少,而CD29⁺在TILs中积累约90%。TILs和自体PBLs用重组白细胞介素-2(rIL-2)进行体外扩增。4周后的平均增殖率在TIL培养物中为642倍,在PBLs中为335倍。超过90%的rIL-2扩增淋巴细胞表达CD2,绝大多数为CD29⁺。体外rIL-2刺激主要在TILs中诱导CD56⁺细胞生长。因此,TILs中CD3⁺和α/β受体的表达较低。那些表型代表淋巴因子激活杀伤细胞的细胞对自体肿瘤以及异基因K562和Daudi靶标具有裂解活性。与PBLs相比,由于TILs在rIL-2长期培养中有更好的增殖反应,TILs对自体和异基因肿瘤靶标的裂解活性明显更高。